301 related articles for article (PubMed ID: 9824603)
21. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
Lee SY; Lee KJ; Kim SJ; Cho SW
Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
[TBL] [Abstract][Full Text] [Related]
22. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
Jung HK; Halder S; McNally M; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ
Aliment Pharmacol Ther; 2007 Aug; 26(3):453-61. PubMed ID: 17635380
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study.
Haque M; Wyeth JW; Stace NH; Talley NJ; Green R
N Z Med J; 2000 May; 113(1110):178-81. PubMed ID: 10917077
[TBL] [Abstract][Full Text] [Related]
24. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
[TBL] [Abstract][Full Text] [Related]
25. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms.
Yarandi SS; Nasseri-Moghaddam S; Mostajabi P; Malekzadeh R
World J Gastroenterol; 2010 Mar; 16(10):1232-8. PubMed ID: 20222167
[TBL] [Abstract][Full Text] [Related]
26. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
27. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study.
Wong WM; Lai KC; Lam KF; Hui WM; Huang JQ; Xia HH; Hu WH; Lam CL; Chan CK; Lam SK; Wong BC
Aliment Pharmacol Ther; 2004 Oct; 20(7):803-12. PubMed ID: 15379841
[TBL] [Abstract][Full Text] [Related]
28. Irritable bowel, smoking and oesophageal acid exposure: an insight into the nature of symptoms of gastro-oesophageal reflux.
Zimmerman J
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1297-303. PubMed ID: 15606391
[TBL] [Abstract][Full Text] [Related]
29. The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study.
Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
Aliment Pharmacol Ther; 2013 Feb; 37(3):323-31. PubMed ID: 23190336
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis.
Lovell RM; Ford AC
Am J Gastroenterol; 2012 Dec; 107(12):1793-801; quiz 1802. PubMed ID: 23032982
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms.
Miele L; Cammarota G; Vero V; Racco S; Cefalo C; Marrone G; Pompili M; Rapaccini G; Bianco A; Landolfi R; Gasbarrini A; Grieco A
Dig Liver Dis; 2012 Dec; 44(12):1032-6. PubMed ID: 22963909
[TBL] [Abstract][Full Text] [Related]
32. Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.
Irvine AJ; Pinto-Sanchez MI; Bercik P; Moayyedi P; Ford AC
Scand J Gastroenterol; 2017 Apr; 52(4):396-402. PubMed ID: 27973922
[TBL] [Abstract][Full Text] [Related]
33. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
Chang L
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
[TBL] [Abstract][Full Text] [Related]
34. Nondigestive symptoms in non-erosive reflux disease: nature, prevalence and relation to acid reflux.
Hershcovici T; Zimmerman J
Aliment Pharmacol Ther; 2008 Nov; 28(9):1127-33. PubMed ID: 18702676
[TBL] [Abstract][Full Text] [Related]
35. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis.
Eusebi LH; Ratnakumaran R; Yuan Y; Solaymani-Dodaran M; Bazzoli F; Ford AC
Gut; 2018 Mar; 67(3):430-440. PubMed ID: 28232473
[TBL] [Abstract][Full Text] [Related]
36. Natural history of gastro-oesophageal reflux disease diagnosed in general practice.
Ruigómez A; García Rodríguez LA; Wallander MA; Johansson S; Graffner H; Dent J
Aliment Pharmacol Ther; 2004 Oct; 20(7):751-60. PubMed ID: 15379835
[TBL] [Abstract][Full Text] [Related]
37. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment.
Khoshoo V; Mohnot S; Haydel R; Saturno E; Edell D; Kobernick A
Pediatr Pulmonol; 2009 Nov; 44(11):1070-4. PubMed ID: 19830719
[TBL] [Abstract][Full Text] [Related]
38. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
[TBL] [Abstract][Full Text] [Related]
39. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.
Whiteman DC; Sadeghi S; Pandeya N; Smithers BM; Gotley DC; Bain CJ; Webb PM; Green AC;
Gut; 2008 Feb; 57(2):173-80. PubMed ID: 17932103
[TBL] [Abstract][Full Text] [Related]
40. Assessment of gastro-oesophageal reflux symptoms in Italian physicians -- a survey by Reflux Disease Questionnaire.
Pace F; Molteni P; Casini V; Pallotta S; Bianchi Porro G
Dig Liver Dis; 2008 Apr; 40(4):235-9. PubMed ID: 18243076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
